MAOA and Parkinson disease: Given the pivotal role of MAO-B as a vital enzyme in dopamine metabolism and oxidative damage in the central dopaminergic system, MAO-B inhibitors stand out as a promising pharmaceutical avenue for treating PD, in contrast to MAO-A inhibitors.